×

Do you want to link to this External Site and leave Amgen.com?

YOU ARE NOW LEAVING AMGEN'S WEB SITE. Amgen takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.

×

Do you want to link to this External Site and leave Amgen.com?

YOU ARE NOW LEAVING AMGEN'S WEB SITE. Amgen takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.

×

Do you want to link to this External Site and leave Amgen.com?

YOU ARE NOW LEAVING AMGEN'S WEB SITE. Amgen takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.

×

Do you want to link to this External Site and leave Amgen.com?

YOU ARE NOW LEAVING AMGEN'S WEB SITE. Amgen takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.

×

 

Value-based Contracts

Amgen is a pioneer in developing value-based contracts to help improve patient access to innovative medicines and offer system stakeholders greater budget predictability and risk-sharing.

We collaborate with payers, PBMs, health plans, and other stakeholders to help improve patient access to medicines.

  • Amgen remains a leader in value-based contracts with more than 120 globally
  • Amgen has a number of value-based contracts in the U.S. with a variety of commercial payers

We believe value-based contracts provide a valuable option to payers interested in evolving from volume-based contracts to those focused on the value medicines can bring to patients.

Responsible approach to pricing

Additional Resources: